Jeffrey Kadanoff

Chief Financial Officer

2024 - Current

Managing Director

2019 - 2024

Esplanade Ventures is an early-stage digital health venture fund.

Interim Chief Financial Officer

2020 - 2022

Chief Financial Officer / Consultant

2018 - 2019

Chief Financial Officer

2017 - 2018

Chief Financial Officer

2014 - 2017

Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.

Strategy Consulltant

2013 - 2014

Advise on strategic planning, market feasibility and growth strategy for clients such as Cirque du Soleil, Edipresse and Paladin Labs.

Vice President - Strategic Planning and Development

2011 - 2013

Reporting to the COO, manage a group of 25 employees, as head of strategy for specialty apparel retailer with over $1B in sales. Responsibilities include strategic planning, mergers & acquisitions, corporate development, ecommerce development, customer insights and strategic partnerships.

Principal

1997 - 2011

Collaborate as a trusted advisor with clients’ VPs and C-level executives to drive strategic change and operational improvements. Responsible for strategy, project management, senior client relationships and team management.

Process Engineer

1994 - 1997

Develop several large scale chemical processing plants. Perform key engineering duties ranging from capital and operating cost estimates, equipment design and selection, and plant start-up procedures.